These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22246278)

  • 1. Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Wu L; He Q; Li X
    J Cancer Res Clin Oncol; 2012 May; 138(5):729-37. PubMed ID: 22246278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Chang C; Li X
    Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].
    Zhao YS; Yang R; Gu SC; Guo J; Zhang X; Wu LY; Li X; Chang CK
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):847-51. PubMed ID: 23384909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in FOXO3 and CHEK2 genes and their correlation with clinicopathological findings in myelodysplastic syndromes.
    Sharifi MJ; Zaker F; Nasiri N; Yaghmaie M
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):214-219. PubMed ID: 32217071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
    Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
    Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of hypermethylation of DLC-1 gene in myelodysplastic syndrome patients and effects of decitabine on DLC-1 gene expression].
    Fu HY; Zhou HR; Yan JG; Chen CJ; Shen JZ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):412-417. PubMed ID: 28219126
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes.
    Uchida T; Kinoshita T; Nagai H; Nakahara Y; Saito H; Hotta T; Murate T
    Blood; 1997 Aug; 90(4):1403-9. PubMed ID: 9269757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
    Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
    Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of methylation levels of multi-genes by real-time PCR in patients with myelodysplastic syndrome].
    Wang YC; DU X; Geng SX; Li YY; Weng JY; Lu ZS; Zhong LY; Deng CX; Lai PL; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):254-8. PubMed ID: 21569709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
    Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
    Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
    J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylation of FHIT gene promoter region in DNA from plasma of patients with myelodysplastic syndromes and demethylating effect of decitabine].
    Deng YF; Zhang L; Zhang XQ; Hu MQ; Dai D; Zhang XZ; Xu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1144-8. PubMed ID: 23114136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer.
    Xiao K; Yu Z; Shi DT; Lei Z; Chen H; Cao J; Tian W; Chen W; Zhang HT
    Int J Oncol; 2015 Aug; 47(2):621-31. PubMed ID: 26043875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
    Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
    Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
    Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
    Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.